Germano Geno J purchased $16K of DTIL

Germano Geno J purchased 2,609 shares of PRECISION BIOSCIENCES INC (DTIL) at $6.28 on 2026-09-25.

Original reporting
SEC EDGAR · Germano Geno J
Published Sep 29, 2026, 11:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 29, 2026, 11:15 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$DTIL
Neutral
low confidence
Mentioned
$DTIL
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$DTILNeutralLow
01

Why it matters

The director's modest purchase adds a small positive data point but is unlikely to affect price.

02

Market read

Minor insider buy; limited trading relevance.

03

What to watch

Potential upcoming clinical data could make the insider's stake more meaningful.

Relevance 4/10Novelty 4/10Timing: after-hours filing today

Background

SEC Form 4 filing discloses insider transactions for public companies.

Company-level read

Ticker impact

$DTILNeutralLow confidence
Context

Director Germano Geno J bought 2,609 shares of Precision Biosciences at $6.28, increasing his stake to 47,492 shares.

Expected impact

slight upward pressure as market absorbs the buy signal

Evidence & confidence

The transaction size ($16K) is minor relative to market cap; director purchases are watched but this amount is not material.

Market effects

None significant for the biotech sector.

No regional impact.

Limited to investors tracking insider activity.

Counterpoint

The purchase could be a routine portfolio rebalancing, not a bullish signal.

Key entities

  • Precision Biosciences Inc

    Biotech firm developing gene editing therapies.

  • Germano Geno J

    Director of Precision Biosciences.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$DTILMedAI 8/10

Precision BioSciences, Inc. entered into an underwriting agreement relating to the issuance and sale by the Company of 10,235,077 shares of its common stock…

PRECISION BIOSCIENCES INC (DTIL) filed an SEC Form 8-K — Other Events. Item 8.01 Other Events As previously reported, on November 5, 2026, Precision BioSciences, Inc. (the “Company”) entered into an underwriting agreement relating to the issuance and sale by the Company of 10,235,077 shares of its common stock, $0.000005 par value per share (the “Co

$DTILHighAI 9/10

Precision BioSciences Announces Pricing of $125 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

PRECISION BIOSCIENCES INC (DTIL) filed an SEC Form 8-K — Other Events. Exhibit 99.1 Precision BioSciences Announces Pricing of $125 Million Underwritten Offering of Common Stock and Pre-Funded Warrants DURHAM, N.C.—November 5, 2026 – Precision BioSciences, Inc. (Nasdaq: DTIL) (“Precision”), a clinical stage gene editing company utilizing its novel p